1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(propan-2-yl)methanimidamide, 97%, 5mg

(4-Acetylphenoxy)acetic Acid>98.0%(GC)(T)25g

N-(4-Amino-5-methoxy-2-methylphenyl)benzamide, 98.0%, 100mg

5-Chloro-3-ethynylpyridin-2-amine, 95.0%, 1g

N-(2-chlorobenzyl)-1-propanamine hydrochloride, 95.0%, 1g

SITRAVATINIB, 95%, 5mg

N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANESULFONAMIDE, 95%, 250mg

9-Fluorenylmethyl Chloroformate [N-Protecting Agent for Peptides Research]>97.0%(HPLC)(T)5g

2,6-Di-tert-butyl-4-methylcyclohexan-1-one, 98%, 25g

4'-Nitro-[1,1'-biphenyl]-4-carbaldehyde, 95.0%, 100g

2-Iodobenzothiazole, 95.0%, 10g

Benzo[de]isochromene-1,3-dione, 95.0%, 100g

Ethyl imidazo[1,2-a]pyrazine-2-carboxylate, 95.0%, 25g